ENCRT
Live / Applied — Statement of use — non-final action mailed (as of 02 Oct 2026)
What this means for you
Not registered yet, but its 28 Dec 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98333363
- Mark type
- Word mark
- Filed
- 28 Dec 2023
- Published for opposition
- 26 Nov 2024
- Attorney of record
- Winfield B. Martin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for treatment of chronic diseases by means of gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for implantable cell therapy; living cells for gene and cell therapy, encapsulated cell therapy, and implantable cell therapy; living cells for medical use, namely, implantable cell therapy preparations with encapsulated cells for secreting drugs and/or molecules
- Class 010 — Medical apparatus: Cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell encapsulation devices in the nature of implantable cell therapy delivery ports; implantable cell therapy devices in the nature of implantable cell therapy delivery ports
Owner
- Encellin, Inc., Palo Alto, CA, US
- Encellin, Inc., Palo Alto, CA, US
Prosecution history
- 02 Oct 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 02 Oct 2026 — NON-FINAL ACTION E-MAILED
- 02 Oct 2026 — SU - NON-FINAL ACTION - WRITTEN
- 18 Aug 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 29 Jun 2026 — USE AMENDMENT FILED
- 29 Jun 2026 — TEAS STATEMENT OF USE RECEIVED
- 25 Jun 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2026 — SOU EXTENSION 3 GRANTED
- 24 Jun 2026 — SOU EXTENSION 3 FILED
- 24 Jun 2026 — SOU TEAS EXTENSION RECEIVED
- 08 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 07 Jan 2026 — SOU EXTENSION 2 GRANTED
- 07 Jan 2026 — SOU EXTENSION 2 FILED
- 07 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 03 Jul 2025 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS